RCM

RA Capital Management Portfolio holdings

AUM $9.76B
1-Year Est. Return 103.63%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+103.63%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$8.12B
AUM Growth
+$2.18B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
78
New
Increased
Reduced
Closed

Top Buys

1 +$98.6M
2 +$57.4M
3 +$55.6M
4
LBRX
LB Pharmaceuticals
LBRX
+$28.2M
5
MLYS icon
Mineralys Therapeutics
MLYS
+$25.4M

Top Sells

1 +$92.5M
2 +$48.1M
3 +$40.6M
4
ELVN icon
Enliven Therapeutics
ELVN
+$17M
5
HNGE
Hinge Health
HNGE
+$15.5M

Sector Composition

1 Healthcare 99.83%
2 Financials 0.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ASND icon
1
Ascendis Pharma
ASND
$14.3B
$2.04B 25.19%
10,281,496
RYTM icon
2
Rhythm Pharmaceuticals
RYTM
$6.19B
$574M 7.07%
5,681,359
+120,000
PCVX icon
3
Vaxcyte
PCVX
$8.86B
$431M 5.31%
11,965,991
RNAM
4
Avidity Biosciences
RNAM
$11.2B
$376M 4.64%
8,641,031
+1,375,000
CDTX
5
DELISTED
Cidara Therapeutics
CDTX
$322M 3.97%
3,365,523
SION
6
Sionna Therapeutics
SION
$1.63B
$307M 3.79%
10,445,322
ETNB
7
DELISTED
89bio
ETNB
$292M 3.6%
19,889,683
NAMS icon
8
NewAmsterdam Pharma
NAMS
$4.08B
$288M 3.55%
10,138,938
MLYS icon
9
Mineralys Therapeutics
MLYS
$2.32B
$278M 3.42%
7,323,750
+1,176,470
JANX icon
10
Janux Therapeutics
JANX
$819M
$273M 3.37%
11,189,693
ACLX icon
11
Arcellx
ACLX
$6.58B
$249M 3.07%
3,036,527
LENZ
12
LENZ Therapeutics
LENZ
$422M
$195M 2.4%
4,178,823
TYRA icon
13
Tyra Biosciences
TYRA
$1.78B
$171M 2.1%
12,198,625
EWTX icon
14
Edgewise Therapeutics
EWTX
$3.22B
$169M 2.08%
10,428,437
+525,804
WVE icon
15
Wave Life Sciences
WVE
$2.59B
$133M 1.64%
18,202,009
SEPN
16
Septerna Inc
SEPN
$1.3B
$132M 1.62%
6,995,858
DNTH icon
17
Dianthus Therapeutics
DNTH
$2.39B
$113M 1.39%
2,866,733
BCAX
18
Bicara Therapeutics
BCAX
$919M
$110M 1.35%
6,955,993
GHRS icon
19
GH Research
GHRS
$921M
$110M 1.35%
7,676,697
SPRY icon
20
ARS Pharmaceuticals
SPRY
$917M
$109M 1.35%
10,860,977
NUVL icon
21
Nuvalent
NUVL
$7.92B
$108M 1.33%
+1,246,456
IRON icon
22
Disc Medicine
IRON
$2.51B
$104M 1.28%
1,577,106
VOR icon
23
Vor Biopharma
VOR
$641M
$96.6M 1.19%
1,982,301
-1
FULC icon
24
Fulcrum Therapeutics
FULC
$558M
$94.1M 1.16%
10,229,099
PEPG icon
25
PepGen
PEPG
$428M
$92.7M 1.14%
20,064,545
+9,375,000